PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development

August 29, 2007

PDL BioPharma, Inc. (PDL) announced a significant strategic change to focus the company on the discovery and development of novel antibodies in oncology and select immunological diseases, following a months-long business and portfolio review.
PDL Biopharma